Stock Price
1,310.00
Daily Change
-7.20 -0.55%
Monthly
7.01%
Yearly
-15.02%
Q2 Forecast
1,266.51

Cipla reported INR74.61B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
aTyr Pharma USD 296.74M 295.7M Dec/2025
Brainstorm Cell Therapeutics USD 86K 6K Dec/2025
Capricor Therapeutics USD 59K 0 Dec/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cipla INR 74.61B 19.39B Sep/2025
Dr.Reddys Laboratories INR 104.17B 3.61B Dec/2025
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Immunic USD 333K 156K Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Sun Pharmaceuticals INR 157.04B 26.1B Sep/2025
TherapeuticsMD USD 2.91M 310K Jun/2024
UPL INR 175.45B 16.74B Sep/2025